These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9578732)

  • 21. DNA proliferative index as a marker in Iraqi aneuploid mammary carcinoma.
    al-Alwan NA
    East Mediterr Health J; 2000; 6(5-6):1062-72. PubMed ID: 12197329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metallothionein as an epithelial proliferative compartment marker for DNA flow cytometry.
    Meskel HH; Cherian MG; Martinez VJ; Veinot LA; Frei JV
    Mod Pathol; 1993 Nov; 6(6):755-60. PubMed ID: 8302819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 expression and DNA ploidy pattern in Egyptian colorectal carcinoma.
    Zalata KR; Leech SH; Ming SC; Nasif WA; Nada NA; Mohamed IE; Atallah AM; Gad-el-Hak NA
    Hepatogastroenterology; 2002; 49(47):1225-9. PubMed ID: 12239910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression.
    Soares J; Pinto AE; Cunha CV; André S; Barão I; Sousa JM; Cravo M
    Cancer; 1999 Jan; 85(1):112-8. PubMed ID: 9921982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between DNA ploidy by flow cytometry and chromosome 3 aberration in oral squamous cell carcinoma.
    Hemmer J; Kraft K; Van Heerden WF
    Oncol Rep; 2006 Jan; 15(1):243-6. PubMed ID: 16328063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of DNA ploidy status and cell proliferation induced by preoperative radiotherapy is a prognostic factor in rectal cancer.
    Lammering G; Taher MM; Gruenagel HH; Borchard F; Porschen R
    Clin Cancer Res; 2000 Aug; 6(8):3215-21. PubMed ID: 10955806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
    Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE
    Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometric DNA ploidy and cell proliferative activity in colorectal adenomatous polyps.
    Wielondek M; Wilczak W; Bielicki D; Krygier-Stojałowska A; Marlicz K
    Pol J Pathol; 1998; 49(3):135-9. PubMed ID: 9810170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of cellular proliferative activity and DNA ploidy as a prognostic factor in breast cancer].
    Pisani T; De Iorio P; Cenci M; Midulla C; Valli C; Vecchione A
    Minerva Ginecol; 1999; 51(1-2):1-5. PubMed ID: 10230237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric DNA analysis is useful in detecting multiple genetic alterations in squamous cell carcinoma of the esophagus.
    Watanabe M; Kuwano H; Tanaka S; Toh Y; Sadanaga N; Sugimachi K
    Cancer; 1999 Jun; 85(11):2322-8. PubMed ID: 10357400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
    Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
    J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis.
    André S; Pinto AE; Laranjeira C; Quaresma M; Soares J
    Pathobiology; 2007; 74(6):323-7. PubMed ID: 18087196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Her2/neu analysis in formalin-fixed, paraffin-embedded breast carcinomas: comparison of immunohistochemistry and multiparameter DNA flow cytometry.
    Leers MP; Hoop JG; Nap M
    Anticancer Res; 2003; 23(2A):999-1006. PubMed ID: 12820338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The signaling adapter protein PINCH is up-regulated in the stroma of common cancers, notably at invasive edges.
    Wang-Rodriguez J; Dreilinger AD; Alsharabi GM; Rearden A
    Cancer; 2002 Sep; 95(6):1387-95. PubMed ID: 12216108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Her-2/neu, Ki-67 expression and ploidy in breast carcinoma].
    Lukashina MI; Glukhova EI; Zhukova LG; Ermilova VD; Bogatyrev VN; Baryshnikov AIu
    Arkh Patol; 2003; 65(5):25-9. PubMed ID: 14664144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
    Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
    Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Image and flow cytometric analyses of DNA content in human solid tumors. A comparative study.
    Faranda A; Costa A; Canova S; Abolafio G; Silvestrini R
    Anal Quant Cytol Histol; 1997 Aug; 19(4):338-44. PubMed ID: 9267567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of DNA flow cytometric analysis in patients with nasopharyngeal carcinoma.
    Yip TT; Lau WH; Chan JK; Ngan RK; Poon YF; Lung CW; Lo TY; Ho JH
    Cancer; 1998 Dec; 83(11):2284-92. PubMed ID: 9840527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.